Literature DB >> 9440642

Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms.

B A Hahn1, W B Saunders, W C Maier.   

Abstract

Although there are several symptom classification systems for irritable bowel syndrome (IBS), for example, the Manning or Rome criteria, there has been no previous research on how well these classifications correspond to each other or to persons diagnosed with IBS. We examined data from the Digestive Disorders Supplement of the 1989 National Health Interview Survey (NHIS) to assess demographic, socioeconomic, and health status characteristics of two groups of IBS sufferers--those who met the Manning or Rome criteria and those who reported having IBS but did not meet either criteria. The results showed that the overlap between estimates of IBS and persons with IBS-like symptoms depended on the definition of IBS. There were socioeconomic differences between the two IBS groups and higher rates of functional or work-related activity limitation and health care utilization for all IBS groups relative to US national averages. In summary, these findings indicate that IBS affects a large portion of the US population, regardless of the definition used to describe the condition. Our results suggest that there is a large undiagnosed population with numerous symptoms consistent with IBS, but further research is required to determine the differences between people who do and do not seek care, their impact on the health care system, and future therapies to reduce symptomatology and suffering.

Entities:  

Mesh:

Year:  1997        PMID: 9440642     DOI: 10.1023/a:1018889318063

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

Review 1.  The irritable bowel syndrome: review and a graduated multicomponent treatment approach.

Authors:  D A Drossman; W G Thompson
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

2.  Health care utilization: the effect of extending insurance to adults on Medicaid or uninsured.

Authors:  B Hahn
Journal:  Med Care       Date:  1994-03       Impact factor: 2.983

3.  Irritable bowel syndrome in office-based practice in the United States.

Authors:  J E Everhart; P F Renault
Journal:  Gastroenterology       Date:  1991-04       Impact factor: 22.682

4.  Towards positive diagnosis of the irritable bowel.

Authors:  A P Manning; W G Thompson; K W Heaton; A F Morris
Journal:  Br Med J       Date:  1978-09-02

Review 5.  Irritable bowel syndrome: pathogenesis and management.

Authors:  W G Thompson
Journal:  Lancet       Date:  1993-06-19       Impact factor: 79.321

6.  U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.

Authors:  D A Drossman; Z Li; E Andruzzi; R D Temple; N J Talley; W G Thompson; W E Whitehead; J Janssens; P Funch-Jensen; E Corazziari
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

7.  Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders.

Authors:  N J Talley; A L Weaver; A R Zinsmeister; L J Melton
Journal:  Am J Epidemiol       Date:  1992-07-15       Impact factor: 4.897

  7 in total
  15 in total

Review 1.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

Review 2.  Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

Authors:  F A Luscombe
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

3.  Prevalence and impact of self-reported irritable bowel symptoms in the general population.

Authors:  K Van den Houte; F Carbone; J Pannemans; M Corsetti; B Fischler; H Piessevaux; J Tack
Journal:  United European Gastroenterol J       Date:  2018-12-22       Impact factor: 4.623

4.  Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome.

Authors:  Eric D Shah; Mark S Riddle; Christopher Chang; Mark Pimentel
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

5.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology.

Authors:  Tara J Taylor; Nader N Youssef; Ravi Shankar; David E Kleiner; Wendy A Henderson
Journal:  BMC Res Notes       Date:  2010-10-21

7.  Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease.

Authors:  K T Park; Raymond Tsai; Louise Wang; Nasim Khavari; Laura Bachrach; Dorsey Bass
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-26       Impact factor: 11.382

Review 8.  Applying case definition criteria to irritable bowel syndrome.

Authors:  Steven H Yale; A Kenneth Musana; Amy Kieke; Jennifer Hayes; Ingrid Glurich; Po-Huang Chyou
Journal:  Clin Med Res       Date:  2008-05

9.  Prevalence of irritable bowel syndrome: a community survey.

Authors:  Sue Wilson; Lesley Roberts; Andrea Roalfe; Pam Bridge; Sukhdev Singh
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

10.  Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions.

Authors:  Ellen A Schur; Niloofar Afari; Helena Furberg; Megan Olarte; Jack Goldberg; Patrick F Sullivan; Dedra Buchwald
Journal:  J Gen Intern Med       Date:  2007-06       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.